Yangi studies and HAS advertorials are clear as mud... you need to do the maths on Stage 1 from basics to see what is really going on.
Below is basic table I did up a while back on LOM assuming Stage 1 mon-con only (they have to actually make profits first to stay in business and build Stage 2 right). Using mine recoveries, we get an average 34kt to Mon-con, containing an avg 9.318kt TREO (ie 27% TREO in con).
Ann OPEX Stage 1 = ~A$200M, or A$21.5/kg TREO in com. 37% of TREO = NdPr, and NdPr = 90% basket value, thus the Ann Opex of A$200M = A$52.2/kg NdPr equivalent (ie $21.5/0.37*0.9).
Difficult to expect higher than 40% payability of REO basket to mon-con seller (tradionally mid to high 30's%). Losses to MREC, losses to RE-Oxides refinery, separation costs (opex and capex deprec'n) mon-con leaching, MREC, Oxide refining profit margins etc all need to be accounted for from monazite 'basket value'.
At 40% payability, A$130/kg NdPr price is required to generate A$52.2/kg NdPr sales revenue, which generates ~A$200M mon-con revenue to cover the ~A$200M OPEX (ie breakeven). At 66c AUD FX, Yangi thus requires US$86.1/kg NdPr price to break even. Breakeven does not cover any capex, debt repayments or debt interest payments. Yangi requires a price significantly above US$86.1/kg NdPr to make profits, cover debt interest, pay tax with enough free-cash left over to then repay debt (debt principal is repaid from after-tax cash).
At least 50% above breakeven as rule of thumb to even consider funding, so minimum NdPr $130/kg NdPr to be considered fundable (about same as the early years NdPr price assumed by HAS in latest Yangi DFS Update... about half the current NdPr price including 13% VAT in China). Off-take to middleman Trading House will clip the ticket and probably sell to China as no other mon-con refineries yet approved or not full of their own planned mon-con ore feed (inc ILU and LYC).
Beware, Yangi is NOT low cost compared to the existing big producers and better wannabes...
- Forums
- ASX - By Stock
- HAS
- Ann: FY23 Corporate Presentation - Year in Review
Ann: FY23 Corporate Presentation - Year in Review, page-12
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HAS (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $52.43M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 28.5¢ | $47.25K | 162.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 59898 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 21000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 59898 | 0.290 |
8 | 129386 | 0.285 |
7 | 264469 | 0.280 |
5 | 103000 | 0.275 |
8 | 111142 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 21000 | 2 |
0.300 | 60572 | 9 |
0.310 | 800 | 1 |
0.315 | 48720 | 1 |
0.320 | 5000 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
HAS (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online